3D HoloGroup,CommunicatAR Product Moves into Trial Stage

FT. LAUDERDALE, Fla. - Dec. 22, 2022 - PRLog -- 3D HoloGroup has moved its CommunicatAR to trial stage. The CommunicatAR product has started in trials and being tested by trained Speech Language Pathologists (SLP) and patients. The product will be put through rigorous tests and feedback will be acquired. CommunicatAR is a speech generating device (SGD) the helps enable users to communicate with the world around them of which could not before. CommunicatAR's ability to help patients communicate, whom of which may lack dexterity and/or are unable to speak. Patients whom suffer in various disease states such as autism, aphasia, post traumatic syndrome, Parkinson's, stroke, are open to trial CommunicatAR. Speech Generating Devices also known as voice output communication aids, are electronic augmentative and alternative communication (AAC) systems used to supplement or replace speech or writing for individuals with severe speech impairments. This technology enables individuals to verbally communicate. SGDs are important for people who have limited means of interacting verbally, as they allow individuals to become active participants in communication interactions. CommunicatAR is an SGD/AAC device that uses augmented reality and 3D HoloGroup's I-SAID technologies.

For more information and to sign up, please visit https://www.3dhologroup.com/free-trials/